{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:36:56Z","timestamp":1792100216201,"version":"4.4.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["614739-A_HERO"],"award-info":[{"award-number":["614739-A_HERO"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005008","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T13:32:02Z","timestamp":1474032722000},"page":"e0005008","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial"],"prefix":"10.1371","volume":"10","author":[{"given":"Beatrice","family":"Barda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean T.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Puchkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Huwyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hattendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"DG Colley","year":"2014","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition","volume":"386","author":"CJL Murray","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.actatropica.2010.08.020","article-title":"From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis","volume":"120","author":"J Utzinger","year":"2011","journal-title":"Acta Trop"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000504","article-title":"Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of <italic>Schistosoma mansoni<\/italic>","volume":"3","author":"SD Melman","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002975","article-title":"Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against <italic>Schistosoma haematobium<\/italic>: A randomized, exploratory, open-label trial","volume":"8","author":"J Keiser","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1016\/S2214-109X(13)70078-0","article-title":"The drug and vaccine landscape for neglected diseases (2000\u201311): a systematic assessment","volume":"1","author":"B Pedrique","year":"2013","journal-title":"Lancet Glob Health"},{"key":"ref7","first-page":"187","article-title":"Studies on the efficacy of artemether in experimental schistosomiasis","volume":"17","author":"WJ Le","year":"1982","journal-title":"Acta Pharmaceutica Sinica"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"WE Ho","year":"2014","journal-title":"Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e3282f19ec4","article-title":"Artemisinins and synthetic trioxolanes in the treatment of helminth infections","volume":"20","author":"J Keiser","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.actatropica.2013.01.009","article-title":"Advances with the Chinese anthelminthic drug tribendimidine in clinical trials and laboratory investigations","volume":"126","author":"SH Xiao","year":"2013","journal-title":"Acta Trop"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/AAC.01537-06","article-title":"In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species","volume":"51","author":"SH Xiao","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1177\/0091270010385578","article-title":"Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with <italic>P<\/italic>. <italic>falciparum<\/italic> malaria","volume":"51","author":"A Gautam","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jcph.232","article-title":"Safety, tolerability and pharmacokinetic profile of single and multiple oral doses of arterolane (RBx11160) maleate in healthy subjects","volume":"54","author":"N Saha","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/2141-9248.139270","article-title":"Fixed dose combination of arterolane and piperaquine: a newer prospect in antimalarial therapy","volume":"4","author":"C Patil","year":"2014","journal-title":"Ann Med Health Sci Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.actatropica.2014.12.005","article-title":"Efficacy of Synriam<sup>TM<\/sup>, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of <italic>Schistosoma mansoni<\/italic>","volume":"143","author":"SF Mossallam","year":"2015","journal-title":"Acta Trop"},{"key":"ref16","first-page":"139","article-title":"Efficacy of moxidectin for the prevention of adult heartworm (<italic>Dirofilaria immitis<\/italic>) infection in dogs","volume":"43","author":"C Genchi","year":"2001","journal-title":"Parassitologia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13071-015-0779-4","article-title":"The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data","volume":"8","author":"HC Turner","year":"2015","journal-title":"Parasit Vectors"},{"key":"ref18","unstructured":"Attah SK. Effect of a single dose of 8 mg moxidectin or 150 \u00b5g\/kg ivermectin on intestinal helminths in participants of a clinical trial conducted in Northeast DRC, Liberia and Ghana. [Internet]. [cited 17 Mar 2016]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.researchgate.net\/publication\/270214613_Effect_of_a_single_dose_of_8_mg_moxidectin_or_150_gkg_ivermectin_on_intestinal_helminths_in_participants_of_a_clinical_trial_conducted_in_Northeast_DRC_Liberia_and_Ghana\" xlink:type=\"simple\">https:\/\/www.researchgate.net\/publication\/270214613_Effect_of_a_single_dose_of_8_mg_moxidectin_or_150_gkg_ivermectin_on_intestinal_helminths_in_participants_of_a_clinical_trial_conducted_in_Northeast_DRC_Liberia_and_Ghana<\/ext-link>"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e2953","DOI":"10.1371\/journal.pntd.0002953","article-title":"A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in <italic>Onchocerca volvulus<\/italic> infection","volume":"8","author":"K Awadzi","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e1917","DOI":"10.1371\/journal.pntd.0001917","article-title":"Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for <italic>Schistosoma mansoni<\/italic> and <italic>S<\/italic>. <italic>haematobium<\/italic>","volume":"6","author":"JT Coulibaly","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref21","first-page":"397","article-title":"A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni","volume":"14","author":"N Katz","year":"1972","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eplepsyres.2005.09.019","article-title":"Proof of Principle studies","volume":"68","author":"B Schmidt","year":"2006","journal-title":"Epilepsy Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0001-706X(02)00135-3","article-title":"Association between <italic>Schistosoma mansoni<\/italic> and hookworm infections among schoolchildren in C\u00f4te d\u2019Ivoire","volume":"84","author":"J Keiser","year":"2002","journal-title":"Acta Trop"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-3156.1998.00292.x","article-title":"<italic>Schistosoma mansoni<\/italic>, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western C\u00f4te d\u2019Ivoire","volume":"3","author":"J Utzinger","year":"1998","journal-title":"Trop Med Int Health TM IH"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1301956","article-title":"Oxantel pamoate-albendazole for <italic>Trichuris trichiura<\/italic> infection","volume":"370","author":"B Speich","year":"2014","journal-title":"N Engl J Med"},{"key":"ref26","article-title":"Report of a WHO Expert Committee","volume":"912","year":"2002"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpddr.2014.07.002","article-title":"Repurposing drugs for the treatment and control of helminth infections","volume":"4","author":"G Panic","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.14411\/fp.2014.068","article-title":"Moxidectin causes adult worm mortality of human lymphatic filarial parasite <italic>Brugia malayi<\/italic> in rodent models","volume":"61","author":"M Verma","year":"2014","journal-title":"Folia Parasitol (Praha)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e3286","DOI":"10.1371\/journal.pntd.0003286","article-title":"Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials","volume":"8","author":"J Zwang","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003821","article-title":"Toward measuring Schistosoma response to praziquantel treatment with appropriate descriptors of egg excretion","volume":"9","author":"PL Olliaro","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/14787210.2013.811931","article-title":"Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis","volume":"11","author":"JR Stothard","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4269\/ajtmh.2004.71.778","article-title":"Efficacy of praziquantel against <italic>Schistosoma haematobium<\/italic> infection in children","volume":"71","author":"Tchuent\u00e9 LA Tchuem","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref33","first-page":"15058","article-title":"New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China","volume":"19","author":"YX Liu","year":"2014","journal-title":"Mol Basel Switz"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1756-3305-4-201","article-title":"Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis","volume":"4","author":"R Liu","year":"2011","journal-title":"Parasit Vectors"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00436-013-3724-5","article-title":"Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of <italic>Schistosoma japonicum<\/italic>","volume":"113","author":"W Wang","year":"2014","journal-title":"Parasitol Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1179\/2047773212Y.0000000038","article-title":"The role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis","volume":"106","author":"PE Wikman-Jorgensen","year":"2012","journal-title":"Pathog Glob Health"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e2431","DOI":"10.1371\/journal.pntd.0002431","article-title":"Meta-analysis of urine heme dipstick diagnosis of <italic>Schistosoma haematobium<\/italic> infection, including low-prevalence and previously-treated populations","volume":"7","author":"CH King","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/cid\/ciw029","article-title":"A Phase 3, double-blind, randomized study of arterolane maleate\u2013piperaquine phosphate vs artemether\u2013lumefantrine for falciparum malaria in adolescent and adult patients in Asia and Africa","volume":"62","author":"OA Toure","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/cis475","article-title":"Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated <italic>Plasmodium falciparum<\/italic> malaria: A comparative, multicenter, randomized clinical trial","volume":"55","author":"N Valecha","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T12:58:29Z","timestamp":1568379509000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005008"}},"subtitle":[],"editor":[{"given":"Abhay R","family":"Satoskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005008","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]}}}